tirzepatide pregnancy news Is OZEMPIC the answer to our fertility struggles? Not so fast — read along to learn more on why there has been a baby boom with the rise of glp-1 medications it's ACP issues guidance on medications

The most common side effects for both injectable and oral forms of semaglutide (Wegovy) include gut issues, such as nausea, vomiting, diarrhea, and constipation, said Hamlet Gasoyan, PhD, assistant professor of medicine at Cleveland Clinic Lerner College of Medicine

Insulin resistance and diabetes medications can affect the rate of weight loss

Ozempic (semaglutide) is a diabetes medication that often leads to weight loss as a secondary benefit

Conclusion In the field of obesity, tirzepatide, although not yet approved by the FDA for weight loss, has superior clinical data to Wegovy (Figure 2)

Large real-world study (2024): In 83,825 patients with obesity, semaglutide was associated with a ~50% lower risk of new or recurrent AUD compared with other anti-obesity meds over 12 months

Mounjaro [package insert]